Lucy Her

Effect of CES1 genetic variation on enalapril steady‐state pharmacokinetics and pharmacodynamics in healthy subjects

Hee Jae Choi, Xinwen Wang, Hao-Jie Zhu, 2021, British journal of clinical pharmacology.

Developing a SWATH capillary LC-MS/MS method for simultaneous therapeutic drug monitoring and untargeted metabolomics analysis of neonatal plasma.

Xinwen Wang, Hao-Jie Zhu, Jingcheng Xiao, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers

Xinwen Wang, Jingcheng Xiao, Jian Shi, 2021, Clinical and translational science.

Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators

Lucy Her, Hao‐Jie Zhu, 2019, Drug Metabolism and Disposition.

FRACPRED‐2D‐PRM: A Fraction Prediction Algorithm‐Assisted 2D Liquid Chromatography‐Based Parallel Reaction Monitoring‐Mass Spectrometry Approach for Measuring Low‐Abundance Proteins in Human Plasma

Xinwen Wang, Jingcheng Xiao, Jian Shi, 2020, Proteomics.

Identification of regulatory variants of carboxylesterase 1 (CES1): A proof‐of‐concept study for the application of the Allele‐Specific Protein Expression (ASPE) assay in identifying cis‐acting regulatory genetic polymorphisms

Xinwen Wang, Hui Jiang, Bing He, 2022, Proteomics.

Minireview Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators

Lucy Her, Hao-Jie Zhu, 2022 .